Ipilimumab + nivolumab
|
Polymyositis with respiratory involvement
|
Yes
|
Yes
|
3
|
Corticosteroid, infliximab, IVIG, Pex
|
NCT01928394
|
[35]
|
Nivolumab
|
Myositis with respiratory failure
|
Yes
|
–
|
7
|
Corticosteroid
|
–
|
[36]
|
Nivolumab
|
Myasthenia crisis and polymyositis requiring ventilation
|
Yes
|
No
|
2
|
Corticosteroid, Pex, IVIG pyridostigmine
|
–
|
[19]
|
Pembrolizumab
|
Polyarticular tenosynovitis and proximal myositis
|
No
|
–
|
56
|
Sulfasalazine
|
NCT01295827
|
[37]
|
Pembrolizumab
|
Exacerbation of preexisting myositis
|
Yes
|
–
|
1
|
IVIG
|
–
|
[38]
|
Ipilimumab
|
Dermatomyositis
|
Yes
|
–
|
2
|
Corticosteroid
|
–
|
[39]
|
Pembrolizumab / ipilimumab
|
Rhabdomyolysis associated with hypothyroidism
|
Yes
|
–
|
6
|
Levothyroxine
|
–
|
[40]
|
Ipilimumab
|
Combined myasthenia and myositis with AChR
|
Yes
|
Yes
|
7
|
Corticosteroid, IVIG
|
–
|
[26]
|
Ipilimumab
|
Retrobulbar weakness with proximal myositis.
|
Yes
|
Yes
|
7
|
Corticosteroid, IVIG
|
–
|
[3]
|
Ipilimumab
|
Orbital myositis associated with ipilimumab
|
–
|
–
|
12
|
Corticosteroid
|
–
|
[41]
|
Tremelimumab + durvalumab
|
Described in text.
|
No
|
Yes
|
4
|
Corticosteroid, Pex, IVIG
|
NCT02000947
| |